Infective Endocarditis due to Ochrobactrum anthropi in a Hemodialysis Patient: A Case Report.
- Author:
Hee Ja KO
1
;
Eun Jung LEE
;
Tae Hyong KIM
;
A Ra CHO
;
Yon Hee PARK
;
Jin Seok JEON
;
Tae Youn CHOI
Author Information
1. Department of Internal Medicine, University of Soon Chun Hyang College of Medicine, Seoul, Korea. shegets@hosp.sch.ac.kr
- Publication Type:Case Report
- Keywords:
Ochrobactrum anthropi;
Infective endocarditis
- MeSH:
Amikacin;
Anti-Bacterial Agents;
Aortic Valve;
Bacillus;
Ciprofloxacin;
Endocarditis;
Gentamicins;
Humans;
Korea;
Ochrobactrum;
Ochrobactrum anthropi;
Renal Dialysis;
Thienamycins;
Trimethoprim, Sulfamethoxazole Drug Combination
- From:Korean Journal of Nephrology
2009;28(6):675-680
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Ochrobactrum anthropi is an aerobic, gram-negative, motile, non-lactose-fermenting, oxidase-producing, and urease-positive bacillus. We reported a case of aortic valve endocarditis due to O. anthropi in a hemodialysis patient. To our knowledge, this is the first case of O. anthropi endocarditis in a hemodialysis patient in Korea. The organism was resistant to beta-lactam antibiotics and susceptible to ciprofloxacin, amikacin, trimethoprim-sulfamethoxazole, gentamicin and carbapenem. We treated O. anthropi endocarditis with meropenem for 6 weeks and the patient recovered completely.
